glp-1 obesity drug news october 9 2025 Outlook for in 2026: From Consolidation to Acceleration Half of people stop taking
Description
These drugs mimic the action of naturally occurring GLP-1, an incretin hormone produced in the intestine in response to food intake
Avoid fatty, greasy, or spicy foods, especially in the first few months
Hydration requires deliberate attention
The excessive weight gain further fuels the disease by worsening insulin resistance, dyslipidemia, hypertension, and pancreatic a-cell failure, resulting in a downward spiral [2]
GLP-1 drugs are authorised for weight loss, and none are intended for cosmetic or aesthetic uses
